ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹û

XClose

ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûModule Catalogue

Home
Menu

Immunodeficiency and Therapeutics (INIM0030)

Key information

Faculty
Faculty of Medical Sciences
Teaching department
Division of Infection and Immunity
Credit value
15
Restrictions
Priority will be given to students on the Division of Infection and Immunity programmes. Other students will be accepted based on availability and on a case-by-case basis. Pre-requisites for UG students: you must have done either INIM0005 Immunology or INIM0006 Immunology in Health and Disease.
Timetable

Alternative credit options

There are no alternative credit options available for this module.

Description

The immune system comprises components that are involved in recognition of invading pathogens and other noxious agents, microbial killing and tissue homeostasis/repair. Therefore, deficiencies of the immune system are associated with increased susceptibility to infectious disease or a failure to control inflammation. The study of immunodeficiencies has in fact contributed extensively to our current understanding of normal structure and function in the immune system, and in turn has led innovative approaches to manipulate immune responses for therapeutic purposes.

This module seeks to explore the broad repertoire of both genetic (primary immunodeficiency) and environmental (secondary immunodeficiency) causes of impaired immunity, together with the consequences for the patient of such deficiencies and the insights provided into our understanding of the normal immune system. The treatment options that are available for these will be discussed, as well as approaches to immunomodulation including research which aims to transform gene and cell therapies into clinical applications.

Learning outcomes

In this module we aim to give you the framework and examples by which:

  • To understand the molecular basis and medical importance of selected humoral and cellular primary immunodeficiency syndromes.
  • To understand contemporary research approaches to investigate the molecular mechanisms that underlie primary immunodeficiencies, with specific examples from recent discoveries.
  • To understand the range of disorders associated with acquired immunodeficiency syndrome, focusing on HIV infection and iatrogenic causes such as bone marrow transplantation or immunosuppressive medication.
  • To explore how the study of mechanisms for immunodeficiency provide new insights into normal immunology and opportunities to modulate immune responses for therapeutic applications.
  • To obtain an overview of therapies that target the immune system, including biological agents, T cell or DC therapies and advances in vaccination.

Module deliveries for 2024/25 academic year

Intended teaching term: Term 2 ÌýÌýÌý Undergraduate (FHEQ Level 6)

Teaching and assessment

Mode of study
In person
Methods of assessment
70% Fixed-time remote activity
30% Coursework
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
12
Module leader
Professor Siobhan Burns
Who to contact for more information
siobhan.burns@ucl.ac.uk

Intended teaching term: Term 2 ÌýÌýÌý Postgraduate (FHEQ Level 7)

Teaching and assessment

Mode of study
In person
Methods of assessment
70% Fixed-time remote activity
30% Coursework
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
5
Module leader
Professor Siobhan Burns
Who to contact for more information
siobhan.burns@ucl.ac.uk

Intended teaching term: Term 2 ÌýÌýÌý Undergraduate (FHEQ Level 7)

Teaching and assessment

Mode of study
In person
Methods of assessment
70% Fixed-time remote activity
30% Coursework
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
2
Module leader
Professor Siobhan Burns
Who to contact for more information
siobhan.burns@ucl.ac.uk

Last updated

This module description was last updated on 8th April 2024.

Ìý